Sun Tao,Lin Xiutong,Tang Hui,Yin Yong,Liu Tonghai,Zhang Guifang,Zhu Jian.Application of beam angle optimization for multiple intracranial metastases[J].Chinese Journal of Radiological Medicine and Protection,2015,35(9):674-678
Application of beam angle optimization for multiple intracranial metastases
Received:March 18, 2015  
DOI:10.3760/cma.j.issn.0254-5098.2015.09.008
KeyWords:Multiple intracranial metastases  Intensity-modulated radiotherapy  Beam angle optimization  Dosimetry
FundProject:
Author NameAffiliationE-mail
Sun Tao Department of Radiation Oncology Physicist, Shandong Cancer Hospital, Shandong Provincial Key Laboratory of Radiation Oncology, Jinan 250117, China  
Lin Xiutong Department of Radiation Oncology Physicist, Shandong Cancer Hospital, Shandong Provincial Key Laboratory of Radiation Oncology, Jinan 250117, China  
Tang Hui 济南空军选拔中心  
Yin Yong Department of Radiation Oncology Physicist, Shandong Cancer Hospital, Shandong Provincial Key Laboratory of Radiation Oncology, Jinan 250117, China  
Liu Tonghai Department of Radiation Oncology Physicist, Shandong Cancer Hospital, Shandong Provincial Key Laboratory of Radiation Oncology, Jinan 250117, China lthsdu@163.com 
Zhang Guifang Department of Radiation Oncology Physicist, Shandong Cancer Hospital, Shandong Provincial Key Laboratory of Radiation Oncology, Jinan 250117, China  
Zhu Jian Department of Radiation Oncology Physicist, Shandong Cancer Hospital, Shandong Provincial Key Laboratory of Radiation Oncology, Jinan 250117, China  
Hits: 2636
Download times: 2537
Abstract::
      Objective To study the dosimetric impact of different angle fields in intensity-modulated radiotherapy (IMRT) and the feasibility of beam angle optimization (BAO) for multiple intracranial metastases. Methods In total, 11 patients with multiple intracranial metastases were included in these analyses. Two treatment techniques were designed for each patient: the 7 equal spaced fields (BAF group) IMRT, and 7 fields by beam angle optimization (BAO group) IMRT. The dose distribution in the target, the dose to the organs at risk and normal brain tissues, and total MU in two groups were compared to explore the dosimetric differences. Results In comparison to the BAF group, the BAO group reduced the maximum dose to left and right lenses by an average of 45%, 37% (t=-5.707, -4.438, P<0.05);the mean dose to the left and right eyes were reduced by an average of 42.6%, 44.5% (t=-4.380, -5.638, P<0.05);the maximum dose to the right eyes were reduced by an average of 32.5% (t=-2.518, P<0.05). The maximum dose of the right optic nerve and the mean dose of normal brain tissue were reduced by an average of 23% and 3% (t=-3.105, -3.437, P<0.05), respectively. For the target dose, conformity and homogeneity in PTV, no statistical differences were observed between the two groups (P>0.05). The BAO group reduced the maximum dose of the brainstem and the optic chiasm, as well as the number of MU, however, the differences were not statistically significant (P>0.05). Conclusions In comparison to the BAF group, the BAO group shows a similar target dose and reduces the dose for the organs at risk. For multiple intracranial metastases, IMRT protocols with BAO are feasible and beneficial.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9061684  On-line:0

v
Scan QR Code
&et=DCA5CABA83612A94001BC2CC9F2441FA2D8A6663AB36B7186C9D5906587B509284307DE3E49C49CFBB7493286EA6629F9DB0C9CFD8BA06DE92613FB744E5907887059EBE2865A18DF761114EDC8BD237&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=FFD10F7019FAA9EC&aid=B388734F3248585C969011DD0327D401&vid=&iid=9CF7A0430CBB2DFD&sid=8B1FE194AD66DC3D&eid=DA280A426E11FC95&fileno=20150908&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="FFD10F7019FAA9EC"; var my_aid="B388734F3248585C969011DD0327D401";